• Nextstellis® receives FDA marketing exclusivity and phase III data published

    Thursday May 27th 2021

  • Mithra announces European approval of Estelle®

    Friday May 21st 2021

  • Investment in Flow Cytometry unlocks the secrets of single cells

    Thursday May 20th 2021

  • reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme

    Thursday May 20th 2021

  • Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks

    Thursday May 20th 2021

  • Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting

    Wednesday May 19th 2021

  • Pathomation announces the support for five new digital pathology file formats, including Philips iSyntax

    Tuesday May 18th 2021

  • Indigo Diabetes appoints Paul Moraviec as Chairman of the Board

    Monday May 17th 2021

  • Your news here?

  • Oxurion NV appoints Tom Graney, CFA as Chief Executive Officer

    Monday May 17th 2021

  • Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

    Tuesday May 11th 2021

  • Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance

    Tuesday May 11th 2021


Strategic Partners